GNRH1 and ovarian hyperstimulation syndrome: A recent Cochrane review33 demonstrated that using GnRH agonists for final oocyte maturation triggering is associated with a lower live birth rate; lower ongoing pregnancy rate; lower incidence of mild, moderate, and severe OHSS; and a higher rate of early miscarriage compared with hCG trigger in fresh cycles.